ABSTRACT. Dry eye, an age-related condition, is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance and tear film instability. Environmental factors are also often implicated in dry eye including exposure to pollutants, ultraviolet (UV) radiation and ozone as well as the chronic use of preserved eyedrops such as in the treatment of glaucoma. These factors increase oxidative stress and ocular surface inflammation. Here, we reviewed the cellular, animal and clinical studies that point to the role of oxidative stress in dry eye disease. The biomarkers used to indicate oxidative damage in ocular surface tissues include 8-hydroxy-2 deoxyguanosine (8-OHdG), 4-hydroxynonenal (HNE) and malondialdehyde (MDD). Antioxidative defences in the ocular surface occur in the form of tear proteins such as lactoferrin and S100A proteins, and enzymes such as superoxide dismutase (SOD), peroxidase, catalase and mitochondrial oxidative enzymes. An imbalance between the level of reactive oxygen species (ROS) and the action of protective enzymes will lead to oxidative damage, and possibly inflammation. A small number of interventional studies suggest that oxidative stress may be directly targeted in topical therapy of dry eye treatment. For example, in vitro studies suggest that L-carnitine and pterostilbene, a blueberry component may reduce oxidative stress, and in animal studies, alpha-lipoic acid (ALP) and selenoprotein P may be helpful. Examples of treatments used in clinical trials include vitamin B12 eyedrops and iodide iontophoresis. With recent emphasis on ageing medicine and preventive holistic health, as well as the role of environmental science, research on oxidative stress in the ocular surface is likely to have increasing impact in the coming years.
Introduction
Dry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance and tear film instability with potential damage to the ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface (International Dry Eye WorkShop 2007a) . Epidemiological studies have shown that the incidence of dry eyes increases with age (Jie et al. 2009; Viso et al. 2009 ). This is significant as ageing is associated with increased oxidative stress (Junqueira et al. 2004 ) which is in turn linked to inflammatory pathways (Kruk et al. 2015) . Environmental factors are also often implicated in dry eye; these include exposure to pollutants, UV radiation (Alves et al. 2014 ) and ozone as well as the chronic use of preserved eyedrops such as in the treatment of glaucoma (Jaenen et al. 2007) . For this review article, we searched the PubMed database using the search terms ('oxidative stress', '8-OHdG', 'HNE' or 'ROS') and 'dry eye'. Articles published between January 2000 and April 2015 were reviewed. We included laboratory, animal and clinical studies, and we excluded review articles.
Oxidative stress increases with age. The evidence that links ageing and oxidative stress is found in three animal studies. First, the Cu, Zn SOD family is a major antioxidant system, and mice deficient in Sod1 has accelerated ageing (Kojima et al. 2012) . Second, aged rats were found to have higher frequencies of corneal epithelia metaplasia and lipofuscin-like material accumulating in the cytoplasm which could result from free radical damage, accompanied by declines in the antioxidant marker vitamin E (Batista et al. 2012) . Third, a caloric-restricted diet can prevent agerelated functional decline in many organs (Masoro 2000) . Such rats have reduced oxidative stress, evidenced by decreased concentration of 8-OHdG and decreased staining of HNE, indicators of oxidative damage in the lacrimal gland, when compared to non-caloric-restricted aged rats (Kawashima et al. 2010 ).
The Relevance of Oxidative Stress in Dry Eye
The dry eye cycle is a useful concept that describes the pathogenesis of dry eye and the factors implicated in the development of dry eye syndrome (Baudouin 2001) . Reactive oxygen species (ROS) play a role in various points of the cycle (Fig. 1) . Hence, if dry eye can be targeted at the level of ROS, it may not be necessary to focus on correcting or treating individual points of the dry eye cycle, for example instability, goblet cell function. Conversely, when some of these dry eye pathological processes are treated, the main benefit may be via reduction of ROS. Moreover, ROS levels can be measured in the tears by capillary tube (Hagan et al. 2016 ) and even in conjunctiva cells (by impression; Cejkova et al. 2008) . This allows ROS to be a more appropriate target for treatment and marker of treatment progress than certain factors such as corneal neuropathy where the quantification of neuronal damage in dry eye using techniques like confocal microscopy is not robust or standardized enough to be routinely used yet.
Oxidative Stress and Dry Eye in Laboratory Studies
The evidence that oxidative stress is linked to dry eye emerged from in vitro and animal. Hyperosmolarity of tears is a key pathogenic step in human dry eye as it causes damage to the surface epithelium by activating a cascade of Fig. 1 . The central role of reactive oxygen species (ROS) in propagating the dry eye cycle. Various upstream factors have the potential to transiently increase ROS load in the tear and ocular surface (top half of figure). Antioxidant defences (see main text) are critical in keeping ROS levels below that which will induce excessive stress signalling. Various antioxidant proteins/enzymes are upregulated when the level of ROS increase, which may exert a negative feedback to contain the extent of stress signalling or the level of ROS. Unopposed ROS can directly damage structures such as the tear lipid layer, as well as the myelin sheath of ocular surface nerves, leading to various processes that propagate dry eye (bottom half of figure) . For example, the loss of goblet cells leads to decrease in mucin production, and reduced corneal wettability, and may also contribute to immune dysregulation. Stress signalling is a big contributor to inflammation, and infiltration of immune cells has widespread consequences on the lacrimal gland, meibomian glands, as well as the ocular surface; chronic inflammation eventually reduces specific tear components and therefore the quality/stability of the tear film. In predisposed patients such as diabetics and patients who had corneal refractive surgery, the risk of corneal sensory neuropathy increases, and this may affect ocular surface wound healing, and impact on the amount of tear produced via the lacrimal functional unit. This figure thus shows how ROS play an integral role in facilitating the dry eye cycle. This figure also shows that mere replacement of tear components (bottom of figure) without addressing the ROS is unlikely to arrest the dry eye cycle and will not be a form of definitive treatment. inflammatory events at the ocular surface and a release of inflammatory mediators into the tears (International Dry Eye WorkShop 2007a). In the form of hyperosmolar culture medium, hyperosmolarity is also able to induce oxidative stress in cultured primary human corneal epithelial cells (HCECs). In such experiments, there was increase in ROS production and disruption of levels of oxygenase and antioxidant enzymes, resulting in mitochondrial DNA damage as well as membrane damage shown by oxidative markers in membrane lipid peroxidation . Benzalkonium chloride (BAK), a cationic surfactant commonly used as a preservative in eyedrops, is able to induce oxidative damage in the tear lipid layer. Hyperosmolarity was found to potentiate the toxic effects of BAK in cultured conjunctival epithelial cells (Clouzeau et al. 2012) .
Three mouse and three rat studies point to a relationship between oxidative stress and dry eye disease. We included systemic therapies, in addition to local therapies, in our discussion of animal studies as preclinical studies are often performed to show proof of concept and possible systemic toxicity. First, in Sod1(-/-) mice with compromised antioxidant defences, one could observe atrophy of the acini, fibrosis, infiltration with CD4 + T cells, monocytes and neutrophils in the lacrimal glands. These mice also had decreased production of both stimulated and non-stimulated tears, a decline in total lacrimal derived tear protein (Kojima et al. 2012 ) and increased meibomian gland dysfunction (MGD; Ibrahim et al. 2014) . Meibomian gland (MGD), a problem associated with occlusion of the meibomian gland orifices, disrupts the delivery of critical meibum lipids to the tear film, and consequently disturbs tear stability and aggravates dry eye (Nichols et al. 2011) .
Second, in a novel mev-1 conditional transgenic mouse model (Tetmev-1), mitochondrial oxidative damage in the lacrimal gland was found to induce lacrimal dysfunction, decreasing tear production and increasing ROS formation resulting in dry eye (Fig. 1) . The mev-1 gene encodes Cyt-1, the cytochrome large subunit of succinate-ubiquinone oxidoreductase found in complex II of the mitochondria electron transport chain. This protein is homologous to the succinate dehydrogenase C subunit (SDHC) in humans. The mev-1 gene induced excessive oxidative stress associated with ocular surface epithelial damage and a decrease in tear protein and aqueous tear secretory function (Uchino et al. 2012) .
Third, mouse studies involving induction of diabetes also support the link between oxidative stress and dry eye. SIRT1 is a deacetylase involved in antioxidant activity, DNA repair and ageing, and its levels are controlled by ROS (Haigis & Guarente 2006) . Diabetes induction is associated with increased oxidative stress, as induction was found to be associated with increased expression of SIRT1 and another antioxidant SOD, for up to 4 weeks, and with subsequent downregulation of these molecules at 8 weeks (Liu et al. 2015) . When dry eye was induced by scopolamine hydrobromide injection three times daily in a lowhumidity chamber, there was significantly decreased tear production and increased corneal fluorescein staining, associated with temporal changes of antioxidant changes, suggesting that the induced dry eye disease was indeed related to the oxidative changes.
Three rat studies found association between oxidative stress and dry eye. In a rat model, dry eyes were induced through continuous exposure to low-humidity airflow for 30 days. Immunoreactivity of oxidative stress markers (8-OHdG, HNE and MDD) were found to be increased, together with increased fluorescein staining, a clinical feature of dry eye indicative of epitheliopathy (Nakamura et al. 2007 ). In ageing rats, there was evidence of dry eye predisposition based on alterations of key trafficking proteins required for tear secretion in the lacrimal gland: Rab3d and Rab27b mRNA levels and Rab3d protein expression were decreased, whereas syntaxin levels were increased (Batista et al. 2012) . Rats that underwent antioxidative stress intervention via a 6-month caloric-restricted diet had better lacrimal function compared to non-caloric-restricted controls. Rats with caloric-restricted diet had significantly improved tear as measured by the phenol red thread test after stimulation with Carbachol compared to controls (Kawashima et al. 2010) .
Oxidative Stress and Dry Eye in Cross-Sectional Clinical Studies
Sjogren syndrome decreases lacrimal gland function, reducing tear secretion causing inflammation and ROS formation (Fig. 1 ). In patients with Sjogren syndrome who suffer from dry eye, the expression of late lipid peroxidation markers, HNE and MDD, was found to be increased in the tear film and ocular surface compared to similar patients with no dry eye. The levels of the oxidative markers correlated with various clinical ocular surface parameters such as tear film break-up time (BUT), Schirmer tear value, tear clearance rate, keratoepitheliopathy scores, corneal sensitivity, conjunctival goblet cell density and symptom scores, and may reflect the severity of dry eye disease (Choi et al. 2016b ).
Conjunctival impression cytology in patients with Sjogren syndrome showed a reduction in antioxidant enzymes (SOD, catalase and glutathione peroxidase), and the extent of reduction was correlated with the severity of dry eye symptoms (Cejkova et al. 2008 ). Another similar study in patients with Sjogren syndrome using brush cytology samples found that conjunctival inflammatory cell density and the number of conjunctival epithelial cells stained positively for hexanoyl-lysine and HNE were significantly higher compared to controls (Wakamatsu et al. 2013 ). These studies suggest that the ocular surface inflammation in dry eye was related to the extent of oxidative damage.
The tear fluid represents the extracellular fluid of ocular surface epithelial cells. Therefore, the type and function of tear proteins found in patients with dry eye will inform on the pathological processes that perturbed normal epithelial health. Proteins involved in the activation of host immune response (a-2-HS-glycoprotein, coagulation factor II, transferrin and orosomucoid 1 and 2) and inflammatory response (serpin peptidase inhibitor, clusterin, keratin 1, C3 and 4A) were found in tears of patients with Sjogren syndrome but not in patients with dry eyes without Sjogren syndrome or normal volunteers (Li et al. 2014) . In addition, different levels of these proteins were also found in patients with dry eyes when compared to healthy volunteers. Using iTRAQ technology, levels of alphaenolase, alpha-1-acid glycoprotein 1, S100 A8 (calgranulin A), S100 A9 (calgranulin B), S100 A4 and S100 A11 (calgizzarin) proteins were found to be upregulated while prolactininducible protein (PIP), lipocalin-1, lactoferrin and lysozyme were found to be downregulated in patients with dry eye and MGD when compared to healthy volunteers (Zhou et al. 2009; Tong et al. 2011) . Some of these tear proteins, for example S100A8 and lactoferrin, have previously been linked to regulation of oxidative stress (Clamp & Creeth 1984; Lim et al. 2009 ). Lactoferrin is an iron chelator and serves to mitigate oxidative stressed caused by iron (Gutteridge 1995) . Consequently, these proteome studies support the link between dry eye and oxidative stress and suggest that the inflammation encountered in human dry eye may also be associated with oxidative stress. Despite all these interesting studies, the strength of evidence provided by cross-sectional observational studies is not as robust as interventional studies.
Preclinical Intervention Studies
Studies have shown that certain substances are able to reduce ROS. In cultured HCECs with oxidative stress induced by hydrogen peroxide, incubation with lactoferrin and xanthan gum was able to protect the cells against the detrimental effects of ROS (Amico et al. 2015; Pastori et al. 2015) . Xanthan gum was also able to reduce ROS levels to that of controls (Amico et al. 2015) . In similar cells with oxidative stress induced by BAK, hyaluronic acid and Carbomer 934P were found to be cytoprotective (Debbasch et al. 2002) . L-carnitine and pterostilbene ), a blueberry component, were found to be able to reduce oxidative stress induced by hyperosmolarity in cultured cells. Both molecules were able to reduce the levels of oxidative damage biomarkers and inflammatory mediators, with associated reduction in the levels of antioxidant enzymes Li et al. 2016) . In living cells, the levels of such enzymes are probably tightly regulated in direct response to the ROS threat.
Preclinical interventional studies in mice and rat disease models have shown that oxidative stress may be reduced effectively (Table 1) . In one such study using plant extracts in mice, not only was there oxidative damage in lacrimal gland tissue, there was evidence of ocular surface inflammation: tear interleukin(IL)-1b, tumour necrosis factor(TNF)-a, IL-6, interferon (IFN)-c, and its associated chemokines, and percentage of CD4 + C-X-C chemokine receptor (CR)3 + T cells were increased in the ocular surface. Clinical features of dry eye in this model included reduction of tear production and BUT, and increased corneal fluorescein staining, as well as a reduction of the density of mucus-producing goblet cells. These features were improved by the treatment (Choi et al. 2016a ). Dry eye is prevalent in postmenopausal women as changes in hormone levels during menopause affect MG function, leading to evaporative dry eye and tear instability and hyperosmolarity and generation of ROS (Fig. 1) . In a rat model of postmenopausal dry eye, ALP restored lacrimal function and improvements in the Schirmer test were noted in the treatment group. Alpha-lipoic acid (ALP) is an endogenously synthesized cofactor for mitochondrial enzyme complexes, and its biological effects include sequestration of ROS, interaction and regeneration of other antioxidants such as vitamin C and vitamin E and regulation of redox processes (Andrade et al. 2014 ).
Lactoferrin, a major protein in the tear, has multiple functions including regulation of microbial growth as well as oxidative stress. A study that involved systemic administration of lactoferrin in mice resulted in a reduction of oxidative damage in the lacrimal gland and improvement in tear function (Kawashima et al. 2012 ; Table 1 ).
Intervention Studies in Humans
A small number of clinical trials have suggested that oxidative stress can be a potential therapeutic strategy in dry eyes ( Table 2 ). The scope of this section will be limited to only studies that track oxidative stress in ocular surface or lacrimal tissues. There is the possibility of reducing oxidative stress due to systemic interventions in the form of dietary supplements, vitamins, omega-3 fatty acids, exercise, etc. However, these may have antioxidant effects elsewhere in the body apart from the lacrimal glands and the ocular surface. Almost all forms of topical dry eye therapy that reduced ocular surface damage or improved lubricity and wound healing in the ocular surface may prevent oxidative stress related to inflammation. For simplicity, this article will only include studies which performed the direct assessment of oxidative stress levels. We have excluded studies that documented dry eye parameters but did not quantify the levels of antioxidant enzymes or other markers of oxidative stress within that study (Hitoe et al. 2014) .
The incidence of dry eye syndrome has been found to increase drastically after cataract operation (Li et al. 2007) , and dry eye often occurs after cataract surgery. Clear cornel incisions can damage the corneal nerves and result in decreased corneal sensitivity, which results in less tear produced via the lacrimal functional unit (Sitompul et al. 2008) . Preservatives (such as BAK) used in postoperative eyedrops can increase ocular surface oxidative stress, and meibomian gland function is also affected (Park et al. 2016 ). Surgical stress can induce inflammation and ROS formation, and surgical-induced inflammation can also produce ROS (Fig. 1) . One randomized parallelgroup case-control study involving 80 patients with moderate-to-severe dry eyes compared the effects of preservative-free and preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery. The same schedule was used for both groups of patients (n = 40 in each group), and all patients had BUT of <5 seconds, Schirmer I test score of <10 mm/5 min without anaesthesia and corneal punctate fluorescein staining score of ≥1 in either eye. The patients underwent the same procedure, phacoemulsification and posterior chamber intraocular lens implantation with no complications. After 2 months of follow-up, the ocular surface disease index (OSDI) score, BUT, Schirmer I score, fluorescein staining score, impression cytology findings and goblet cell count were better in the group treated with preservative-free eyedrops. In addition, concentrations of inflammatory markers (IL-1b and TNF-a) in tears were lower in the group treated with preservativefree eyedrops and levels of antioxidants (catalase and SOD2) in tears were lower in the group treated with preserved eyedrops. Hence, using preservative-free eyedrops postoperatively in patients with dry eye can better clinical outcomes by reducing inflammation and ROS production. However, the study did not document the dry eye treatment in the patients in the preoperative period such as the use of artificial tears. The follow-up period was 2 months in this study, and a longer duration of follow-up would be necessary to further quantify the effectiveness of the use of preservative-free eyedrops after cataract surgery (Jee et al. 2015) .
Another study evaluated the effects of preservative-free eyedrops containing hyaluronic acid 0.15% and vitamin B12, an antioxidant, on oxidative stress and dry eye symptoms. This prospective, randomized interventional study enrolled patients with tear film fluorescein clearance test score of more than grade 3, Schirmer's I test result of <10 mm at 5 min, BUT of <10 seconds, an OSDI score indicating mild-to-severe dry eye and no previous therapies for dry eye. All patients were planned for cataract surgery, and 31 patients with dry eye were randomized to receive treatment 1 month before surgery. The patients started treatment with preservative-free eyedrops containing hyaluronic acid 0.15% and vitamin B12 four times a day for a month before surgery while 29 patients with dry eye served as control and received no treatment for their dry eye (in status quo) before surgery. The control group was 42 patients who did not exhibit dry eye signs or symptoms. Conjunctival biopsies were taken from all patients immediately before patients underwent cataract surgery, and levels of oxidative stress on the conjunctival tissue were determined by LP-CHOLOX tests. The LP-CHOLOX test photometrically measures the level of lipoperoxides, a marker of oxidative stress. Patients treated with these eyedrops had significantly reduced oxidative stress based on the LP-CHOLOX tests performed on the conjunctival biopsy taken at surgery, OSDI score and fluorescein clearance test score, and increased Schirmer's test and BUT scores compared with untreated patients with dry eye after 1 month of treatment. The study also showed an increased level of oxidative stress in conjunctival tissue in the group of patients who had no treatment for dry eye when compared to controls. The level of oxidative stress in conjunctival samples was the same in the group with dry eye that was treated and in the control group. Hence, the application of preservative-free eyedrops containing hyaluronic acid 0.15% and vitamin B12 reduces oxidative stress and relieves dry eye symptoms. Limitation of this study includes small sample size and short duration of follow-up and failure to follow-up with dry eye signs and symptoms. Moreover, due to the design of the study, it is not possible to determine whether the benefit of reduction in oxidative stress continues to persist after cessation of treatment (Macri et al. 2015) . In addition, the authors have failed to demonstrate that topical concentrations of vitamin B12 would indeed have an effect on ocular tissue when used at the frequency of the study. There is scope for further studies to better understand the effect of vitamin B12 on ocular tissues and ROS on the ocular surface. -Iodide, a reducing agent and electron donor, has been demonstrated to be an oxygen free radical scavenger in vitro and in vivo (Horwath-Winter et al. 2005) . Iontophoresis is a process by which ions or charged molecules in solution are applied to body surfaces and introduced into cells and tissues with the use of electric current. Iodide iontophoresis increases the water-soluble antioxidative capacity of tear fluid mitigating the effects of ROS, which may alleviate the symptoms of dry eyes (Rieger et al. 2010) . In a non-randomized interventional clinical trial, the effectiveness of iodide iontophoresis and iodide application without current in moderate-to-severe dry eye patients was compared; 16 patients were treated with iodide iontophoresis and 12 patients with iodide application without current for 10 days. Both groups had a reduction in subjective symptoms and frequency of artificial tear substitute application. However, the application of iodide with current (iontophoresis) was more effective than application of iodine solution alone as improvement in BUT, fluorescein and rose bengal staining was observed which persists up to 3 months was noted in the iontophoresis group. Limitations of this study include a small sample size and a lack of randomization (Horwath-Winter et al. 2005) . Iontophoresis is an in-office treatment requiring the use of specialized equipment; it requires patients to visit the clinic ten times over 2 weeks to receive treatment which might not be feasible in routine practice due to the large number of patients with dry eye. In addition, iodine is potentially cytotoxic to both corneal epithelial and endothelial cells (Naor et al. 2001; Jiang et al. 2009; Shibata et al. 2014) .
Larger, possibly multicentre trials with longer follow-up times are needed to conclusively determine the effectiveness of the treatments in the studies above.
Clinical Relevance
The concept of oxidative stress is useful in practice because therapies exist that are efficacious in dry eye but are not traditionally considered to be antiinflammatory in nature, for example the use of enteric lactoferrin. Such treatment can be preventive, or initiated in early dry eye, whereas traditional anti-inflammatory treatment for dry eye is more often initiated in patients with significant ocular surface damage. An example of such an approach will be using contact lens coated with lactoferrin (Pastori et al. 2015) , as contact lens wear is a risk factor for dry eye (Kojima et al. 2011) . This paper will push for researchers to perform assessment of oxidation and related markers in dry eye studies and use more accessible or practical treatment strategies for reducing oxidative stress. Autologous serum eyedrops are recommended for severe dry eyes, as they contain many nutrients and proteins which can improve the extracellular matrix of the ocular surface epithelial cells by facilitating ocular surface maintenance and healing (International Dry Eye WorkShop 2007b) . One study found that the anti-inflammatory cytokines were higher in serum from non-dry eye people compared to dry eye patients (Stenwall et al. 2015) . However, a case-control study reported that there were no significant differences in total antioxidant potential and concentration of ROS in controls and patients with dry eyes (Gus et al. 2016) . In terms of reducing oxidative stress, autologous serum in dry eye patients is therefore as effective as allogenic serum from non-dry eye people.
Future Studies and Challenges
Studies are required to evaluate the role of environmental triggers of oxidative stress, for example pollutants, sunlight and smoking on their contribution to dry eye. Environmental conditions such as the windy and cold temperatures have been known to vary with seasons and aggravate dry eye signs and symptoms (van Setten et al. 2016) . These epidemiological studies will have clinical implications as preventive strategies could be employed in those occupationally at risk. Conjunctival UV autofluorescence has been developed in an attempt to quantify ocular sun exposure (Sherwin et al. 2011) ; however, more validation of the method is necessary before its clinical usefulness can be ascertained.
Systemic or topical antioxidants such as ascorbic acid, lactoferrin and vitamins D or A should be explored further in dry eye. Oral lactoferrin has been evaluated in Sjogren syndrome ). The importance of vitamin C supplementation for the health of the ocular surface and tear has been shown in diabetic people, who are at risk for dry eye (Peponis et al. 2002 (Peponis et al. , 2004 . Vitamin D is a potent antioxidant, and patients with increased levels of serum vitamin D levels were found to have increased BUT and tear secretion (Jin et al. 2017) . Serum vitamin D levels are positively correlated to tear vitamin D levels, with tear vitamin D levels being higher than that of serum levels (Sethu et al. 2016 ). This suggests that orally supplementing the levels of systemic vitamin D may increase tear levels. Future studies should therefore examine the potential alteration of tear vitamin D after oral supplement. Vitamin A has been used topically to protect the conjunctiva of patients with glaucoma and has resulted in improvement in dry eye symptoms . This study should be extended to other dry eye patients. A recent publication involved administration of an oral cocktail of antioxidants in 40 participants in a randomized controlled trial, which found improvement in dry eye symptoms and Schirmer test, but the actual levels of oxidative stress was not measured (Kawashima et al. 2016 ). More studies should be conducted on mediators of oxidative stress such as lipids. Small lipids in the form of eicosanoids have the capacity to be either proinflammatory or anti-inflammatory and pro-resolution (Dennis & Norris 2015) and have been linked to peroxidation of membrane lipids (Sauriasari et al. 2016 ; Van't Erve et al. 2016) . For example, in dry eye, the small lipid prostaglandin E2 (PGE2) has been found to increase and prostaglandin D2 (PGD2) to decrease in the tears (Shim et al. 2012) . Another study found several inflammation-associated bioactive lipid species, such as various lysophosphatidylcholines, as well as their unsaturated phospholipid precursors to differ significantly in quantity amongst patients of different severity levels of dry eyes, as well as between patients and control subjects (Lam et al. 2011) .
We believe that there should be greater consensus in the optimal strategy for evaluation of oxidative stress in the ocular surface, especially in the form of suitable animal models. Potential areas for future study include the route of delivery of antioxidant therapy in the eye. Antioxidative treatment may be delivered by contact lenses (Pastori et al. 2015) , dietary supplements (Hitoe et al. 2014) or topical formulations with favourable pharmacokinetics (Babizhayev 2005 (Babizhayev , 2009 Kador et al. 2014) . It is important to realize that the aim of dry eye therapy is to target ocular surface stress; hence, formulations that optimized intraocular delivery may not be desirable (Babizhayev 2005 (Babizhayev , 2009 . Lipids that are anti-inflammatory and pro-resolution may have therapeutic potential in dry eyes and should be investigated further (Serhan 2014) .
Moving forward, tear-based tests to quantify ROS can be used clinically to determine the patient's ocular ROS status especially with recent advanced in profiling technologies (such as iTRAQ technology) leading to increased accuracy and allowing for quantification of minute samples. Tear-based tests are non-invasive and are preferred to conjunctival impression which is invasive. The metabolomic and proteomic composition of the tear film would include metabolites such as vitamin D levels and levels of biomarkers associated with oxidative stress (e.g. alpha-enolase, alpha-1-acid glycoprotein 1, S100 A8 (calgranulin A), S100 A9, S100 A4 and S100 A11 proteins; Hagan et al. 2016) . The LP-CHOLOX test and selective tear assays on oxidative stress-related proteins may be potentially adapted for clinical use.
Conclusion
The study of oxidative stress in the ocular surface is in the beginning stages, and there is great promise for highly exciting research findings to be translated to clinically useful outcomes. As this area of research impacts on ageing medicine, holistic health as well as environmental science, it is likely to expand. In the meantime, ocular surface practitioners should be aware of the role of oxidative stress in dry eye.
